The FDA has faulted AbbVie’s promotion of the migraine drug Ubrelvy, calling the company out for an ad featuring Serena ...
The next frame shows the Ubrelvy logo in the backstage hallway along with a blue lit path. Frames six to seven then show Serena Williams walking down the blue lit path, no longer exhibiting migraine ...
The Food and Drug Administration recently intervened regarding a migraine medication ad featuring tennis superstar Serena ...
In the ad for oral CGRP inhibitor Ubrelvy (ubrogepant), Williams is depicted as suffering from a migraine while in a talk ...
The U.S. Food and Drug Administration is taking North Chicago-based drugmaker AbbVie to task, warning in a recent letter that ...
A drugmaker's advertisement featuring Serena Williams is under FDA scrutiny for misleading claims that it can quickly cure ...
Atlanta Black Star News on MSN4d
‘Aint She Rich Enuf?’: Serena Williams Under Fire as the FDA Steps In Following ‘Misleading’ Commercial for Migraine Medicine MakerA migraine medicine once-endorsed by Serena Williams has come under fire amid claims advertisements oversold it's usefulness.
Tennis365 on MSN5d
Drugmaker AbbVie scolded by the FDA over ‘misleading’ advert featuring Serena WilliamsUS government watchdog, the Food and Drug Administration have issued official correspondence to drugmakers AbbVie, informing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback